Feature | June 01, 2012 | Thomas S. Chang, M.D., FACR

Fibroglandular Densities & Mammographic Breast Density

Knowledge of one's fibroglandular breast density is important, because high density increases the risk of cancer and decreases the accuracy of mammograms

A comparision of a small breast cancer found in a patient without dense breast tissue (left), and a tumor found in a woman with dense fibroglandular tissue. Fibroglandular Dense Breast tissue Comparison

A comparision of a small breast cancer found in a patient without dense breast tissue (left), and a tumor found in a woman with dense fibroglandular tissue. For more information visit DenseBreast-info.org.

SecondLook Premier software from iCAD marks potential mass (oval) and calcifications (rectangle) on left breast with dense tissue.Breast Density Assessment and Fibroglandular Densities

SecondLook Premier software from iCAD marks potential mass (oval) and calcifications (rectangle) on left breast with dense tissue.

Hologic offers Quantra volumetric breast density assessment software, which uses details of the X-ray imaging chain to quantify fibroglandular tissue in the breast. It aggregates volumetric measurements from each view in a study into a concise assessment for each breast. Hologic, Quantra, volumetric breast density assessment

Hologic offers Quantra volumetric breast density assessment software, which uses details of the X-ray imaging chain to quantify fibroglandular tissue in the breast. It aggregates volumetric measurements from each view in a study into a concise assessment for each breast.

This is an example of the output from Volpara, one of the volumetric breast density assessment tools on the market. Volumetric Breast & Fibrograndular Density Assessment

This is an example of the output from Volpara, one of the volumetric breast density assessment tools on the market.

(This article was updated in July 2016)

There has been much talk in the news lately about mammographic breast density, its association with the risk of breast cancer and legislative efforts to mandate reporting it to patients. This article addresses the reasons why breast density has become such a hot-button issue and what we might expect from this topic going forward.


The Breast Density-Breast Cancer Connection

In 1976, John Wolfe proposed a four-tiered classification of mammographic breast parenchymal patterns, after he had noticed a strong association between parenchymal pattern and breast cancer risk. The more complex (and generally denser) the parenchyma, the higher the risk of subsequent breast cancer. His top category had a breast cancer risk that was 31 times higher than that of his bottom category. Although subsequent analysis concluded that this quoted risk was vastly overstated, experts still considered the density-cancer connection to be valid.

In the early 1990s, researchers studying breast density (rather than parenchymal patterns) found that density itself was a predictor of breast cancer risk. This was the basis for the American College of Radiology’s decision to incorporate a four-tiered breast composition rating as part of its Breast Imaging Reporting and Data System (BI-RADS). The four current categories are:

•     Almost entirely fat (less than 25 percent glandular)

•     Scattered fibroglandular densities (approximately 25-50 percent glandular)

•     Heterogeneously dense (approximately 51-75 percent glandular)

•     Extremely dense (more than 75 percent glandular).

Dozens of studies that have evaluated the association between breast density and breast cancer have found a four-to-six times greater likelihood of developing cancer in the densest category than in the least dense category.


Watch a video interview on breast density from NCoBC 2016


Other Problems with Dense Breast Tissue

Dense breast tissue not only elevates the risk of breast cancer, but also makes it harder to detect mammographically. Cancers, which are white on mammograms, become hidden on a background of dense tissue, which is also white. Whereas the sensitivity of mammography for showing breast cancer is 98 percent for fatty breasts, it drops to only 48 percent for extremely dense breasts. In other words, only half of all breast cancers are visible on mammography when the breasts are dense. Another problem is that women with dense parenchyma are more likely to have breast pain or longer mammography exposure times, both of which can lead to blurry mammograms as a result of patient motion.

Read the 2015 article "Making Sense of Dense Breasts," which discusses new technologies that are available to image dense breasts.


How Can We Improve Breast Cancer Detection in Dense Breasts?

In the multicenter Digital Mammographic Imaging Screening Trial (DMIST), digital mammography was significantly better at showing breast cancer in pre- and perimenopausal women younger than 50 years with dense breasts than analog mammography. Thus, younger women with dense breasts should strive to have their mammograms done on digital units.

The American College of Radiology Imaging Network (ACRIN) conducted trial #6666 (Screening Breast Ultrasound in High-Risk Women) at multiple sites worldwide, including the author’s imaging center. Among women at elevated risk for breast cancer and with >50 percent breast density, the addition of breast ultrasound to mammography increased the cancer detection rate by 55 percent, but with more than double the false-positive rate. The addition of a single breast magnetic resonance imaging (MRI) exam at the end of the study doubled the cancer detection rate over that of mammography plus ultrasound, but also with a further increase in the false-positive rate.

The American Cancer Society currently recommends screening breast MRI for women with at least a 20 percent lifetime risk of breast cancer. Approximately 2 percent of U.S. women would meet this threshold. However, because the various breast cancer risk calculators do not consider breast density, the number of women who could qualify for MRI screening would be higher if density were included.

Other options for evaluating dense breasts include breast-specific gamma imaging (BSGI), also known as molecular breast imaging, and positron emission mammography (PEM). Although these tests use ionizing radiation, they have one notable advantage over ultrasound and MRI — their low false-positive rates result in fewer unnecessary biopsies.


Breast Density in the News

In recent years, breast cancer advocacy groups, such as the aptly named AreYouDense.org, have been spreading the word about the problems associated with dense parenchyma. They also have spotlighted many women who felt that their cancers would have been detected much earlier had they been told of their dense breast tissue.

These efforts have been covered widely by the mainstream media. In 2010, the Los Angeles Times said of breast density, “It just might be the greatest cancer risk you’ve never heard of.”


Breast Density Legislation

All this media attention prompted legislators to take action. In 2009, Connecticut became the first state to require that patients be informed of their mammographic breast density and that insurance policies cover screening breast ultrasound for patients with greater than 50 percent density. Since then, Texas and Virginia have also passed breast density notifications laws. Similar efforts are under way in numerous other states. Insurance coverage has been required in Illinois since 2009, but without the requirement to inform patients.

At the federal level, the Breast Density and Mammography Reporting Act of 2011, sponsored by Rep. Rosa DeLauro of Connecticut, would require written notification to patients about their breast density and availability of supplemental screening tests for women with dense breasts. This House bill is currently under review at the committee level.

Although proponents of these laws argue that the more information patients have about their health, the better they can make informed decisions, many medical groups have voiced concerns. They point out that breast density is a subjective determination that varies from one radiologist to the next and even from day to day for the same radiologist. This can lead to confusion when patients are told that they have dense breasts one year, but not the year before or the year after. Did their risk actually change or was it just a different reader?

Opponents also worry that patients may clamor for additional as-yet-unproven tests that they read about on the Internet, thereby driving up heathcare costs at a time when our country is trying to find ways to contain costs. Because there is much that is unknown about the best way to handle dense breasts, there is valid concern for unintended consequences. Finally, it is possible that women who are told they have fatty breasts may get a false sense of security and have screening mammograms less frequently or not at all.

Read about the questions patients are most likely to ask regarding breast density.


Standardizing Breast Density Measurements

It is clear that for breast density information to be useful and to address the concerns about variability, there has to be a better way to measure density, one that is more objective and reproducible. In older research studies, radiologists had to either draw the boundaries of dense tissue on clear overlays or arbitrarily choose a shade-of-gray threshold between dense and non-dense tissue on a computer monitor. These were certainly not easily reproducible.

More recent studies have used automated algorithms to determine the optimal threshold between dense and non-dense tissue on mammographic images. However, Kopans called into question the validity of using 2-D mammographic data to assess the density of a 3-D organ. He advocated the use of volumetric 3-D information for all future investigations.

Commercial software for volumetric breast density evaluation is now available, including Volpara from Matakina and iCAD (for GE and Hologic digital mammogram systems, the system used in the author’s practice) and Quantra from Hologic (for Hologic digital mammogram systems).


Future Direction

Additional studies will need to be performed to determine whether automated, volumetric breast density assessments predict cancer risk better than subjective visual assessments. With a quantitative, standardized way of reporting breast density, there is now no reason not to incorporate density data into the numerous models that calculate breast cancer risk, especially since breast density is one of the strongest independent risk factors for cancer.

Other questions to consider are: Should all individuals with dense breasts get supplemental testing, such as ultrasound, MRI or BSGI, or only those whose calculated breast cancer risk exceeds a certain threshold? Which supplemental test is best? Is chemoprevention, such as with tamoxifen, indicated in these women? Are the supplemental tests or chemoprevention effective at reducing breast cancer mortality, or are they merely adding to the costs without affecting the end results? Because digital mammography has been shown to improve cancer detection in dense breasts, does digital mammography obviate the need for supplemental testing? Stay tuned for the answers.


Watch a video interview on the latest breast imaging and density reporting technology advances


In Summary

Mammographic breast density is one of the strongest independent risk factors for subsequent breast cancer, stronger than even age or family history. Having dense breast tissue not only increases one’s chances of developing breast cancer, but also makes cancers that do develop more difficult to detect.

Breast ultrasound, MRI and BSGI all increase our ability to detect small breast cancers in dense tissue, but also increase the number of  benign biopsies. Many state legislatures and the U.S. Congress have either passed or are working on laws to require that mammogram patients be informed of their breast density, so that they can seek supplemental testing, if desired. Two states now require health insurance to pay for this supplemental testing for women with breast densities in the top two density categories, encompassing roughly half of all women.

These mandates make it especially important that we have in place a standardized, reproducible way to measure and report breast density. Research continues on the best way to assess breast density and on what should be done with that information.

Thomas S. Chang, M.D., FACR, is a radiologist at Weinstein Imaging Associates, a specialty women’s imaging practice in Pittsburgh, Penn. The practice was a core participant in the American College of Radiology Imaging Network trial on screening breast ultrasound and breast MRI in high-risk women and was an early adopter of breast-specific gamma imaging/molecular breast imaging. Chang was president of the Mammographer’s Society of Pittsburgh and the Pittsburgh Roentgen Society and is now first vice-president of the Pennsylvania Radiological Society. He reviews manuscripts in breast and gynecologic imaging for the American Journal of Roentgenology.

Additional Resources on ITN for Breast Imaging and Dense Breast technology Information

VIDEO: Personalized Breast Screening and Breast Density

New Technology and Clinical Data in Breast Imaging (articles from 2017)

VIDEO: Advances and Trends in Breast Imaging

Trends in Breast Imaging

Making Sense of Dense Breasts

Dense Breast Tissue: Supplemental Imaging

Breast Density: Are You Informed?



Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breas cancer. J Am Med Assoc 2008; 299:2151-2163.
Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227-236.
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evalautions. Radiology 2002; 225:165-175.
Kopans DB. Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk. Radiology 2008; 246:348-353.
• Legislative update. www.AreYouDenseAdvocacy.org, Feb 22, 2012.
Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 2008; 246:376-383.
• Ravn K. Breast density linked to cancer risk. Los Angeles Times, Jun 21, 2010.
Sickles EA. Wolfe mammographic parenchymal patterns and breast cancer risk. Am J Roentgenol 2007; 188:301-303.
• Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 126:1130-1139.

Related Content

A new Yale-led study shows that a portable magnetic resonance imaging (MRI) device can help identify such intracranial hemorrhages, potentially life-saving information particularly in areas or scenarios where access to sophisticated brain imaging scans are not readily available.

Getty Images

News | Magnetic Resonance Imaging (MRI) | August 25, 2021
August 25, 2021 — When patients exhibit stroke symptoms, doctors must quickly make a life or death determination: Are
While doctors have used low-intensity ultrasound as a medical imaging tool since the 1950s, experts at the University of Waterloo are using and extending models that help capture how high-intensity focused ultrasound (HIFU) can work on a cellular level.

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. 

News | Focused Ultrasound Therapy | August 24, 2021
August 24, 2021 — Researchers are bringing the use of acoustic waves to target and destroy cancerous tumors closer to
The Telehealth Service Implementation Model (TSIM) is a roadmap for navigating the complexities of establishing a strong and durable telehealth program

Dr. Dee Ford, program director of the National Telehealth Center of Excellence at the Medical University of South Carolina, demonstrates a telehealth visit. Photo courtesy of Medical University of South Carolina, Sarah Pack

News | Teleradiology | August 24, 2021
August 24, 2021 — Telehealth
Transverse view of as lung CT showing heavy areas of COVID pneumonia in the lungs

Transverse view of as lung CT showing heavy areas of COVID pneumonia in the lungs. The heart is in the center on the image. Getty Images

News | Coronavirus (COVID-19) | August 19, 2021
August 19, 2021 — In a new publication from Cardiovascular Innovations and Applications; ...
Sarcopenia (Myosteatosis) at Screening CT Colonoscopy in 79-Year-Old Woman With Subsequent Hip Fracture

Sarcopenia (Myosteatosis) at Screening CT Colonoscopy in 79-Year-Old Woman With Subsequent Hip Fracture: A & B. Image at L1 vertebral level without (A) and with (B) overlay of automated skeletal muscle segmentation (B, red). Intramuscular fat is present within paraspinal muscles (A, yellow circle). Mean muscle attenuation is similar for manually placed ROI (1.8 HU) and automated tool (3.9 HU), being markedly decreased for both approaches. Muscle cross-sectional area is relatively preserved when intramuscular fat is included.

C & D. CT images at L3 level without (C) and with (D) muscle segmentation demonstrate similar findings.

E. Hip radiograph demonstrates left intertrochanteric femoral fracture that occurred when patient fell 2 years later. Patient died 4 years after falling.

News | Computed Tomography (CT) | August 19, 2021
Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy

Schematic overview of cell cycle regulation, with an emphasis on radiotherapy-induced pathways and CDK/cyclin regulation. In M phase and in G2 resting phase, cancer cells are respectively very sensitive and moderately sensitive to radiation injury, whereas in G1 phase and in S phase, cancer cells are moderately resistant to radiation injury. Irradiation induces G1 and G2 cell cycle checkpoint activation and DNA repair. Most cancer cells are defective in G1 checkpoint, commonly due to the mutations/alterations of the key regulators of the G1 checkpoint, but contain a functional G2 checkpoint. Figure courtesy of The International Journal of Molecular Sciences

News | Radiation Therapy | August 18, 2021
August 18, 2021 — Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy t
DenseBreast-info.org (DB-I) announced that the European Society of Radiology (ESR) now links to DB-I website and educational materials as a resource for members about the screening and risk implications of dense breast tissue.
News | Breast Density | August 13, 2021
August 13, 2021 — 
#coronavirus #COVID19 #pandemic #RSNA21 will require all attendees and exhibitors to show proof of #vaccination and wear a #mask

Getty Images

News | RSNA | August 12, 2021
August 12, 2021 — RSNA 2021 will require proof of CO...

Figure shows coarse attention maps generated using GradCAM for correctly classified high-grade glioma (HGG), low-grade glioma (LGG), brain metastases (METS), meningioma (MEN), acoustic neuroma (AN), and pituitary adenoma (PA). For each pair, the postcontrast T1-weighted scan, and the GradCAM attention map (overlaid on scan) have been shown. In GradCAM maps, warmer and colder colors represent high and low contribution of pixels toward a correct prediction, respectively. Image courtesy of the Radiological Society of North America

News | Artificial Intelligence | August 12, 2021
August 12, 2021 — A team of researchers at Washington Universit...